10 / 10
Note:
Ortho Congress 2019
Journal of Orthopedic Surgery and Rehabilitation | ISSN: 2630-4473 | Volume 3
Page 35
April 15-16, 2019 | Milan, Italy
ORTHOPEDICS, RHEUMATOLOGY
AND OSTEOPOROSIS
2
nd
Annual Conference on
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
Current treatment:
SERMS 1%, BPs 85, 7%, Denosumab 11, 6%, StrontiumRanelate 0, 2%, Teriparatide 1, 6%. Vitamin D:
40, 6%, Alphacalcidol: 8, 1%, Calcium supplements: 38, 6%.
History of vertebral fracture:
11, 1%; fractures were diagnosed in 25, 4% of the patients (the prevalence of vertebral
fractures among people treated for osteoporosis in Greece. Among 419 patients actually found with fracture(s), only 98
(23, 4%) knew about the existence of the fracture(s). On the contrary, among the rest 1233 patients actually found with-
out fracture(s), 86 (7, 0%) had declared knowledge about the existence of fracture(s) in their history. For 1289 patients
(78%) out of the total 1652, orthopedics could read the opinion of the radiologist about the existence of fracture(s). In
accordance with the diagnosis about the existence of fracture(s) between radiologist and orthopedic was achieved in
1088 patients (84, 4%).
Conclusions:
Vertebral fracture prevalence among people treated for osteoporosis in Greece is 25, 4%; 76, 6%of people
treated for osteoporosis in Greece, think they don’t have fracture(s), although they do. According to the existence of
vertebral fractures between radiologists and orthopedics in Greece is not very high (84, 4%).